Zhou Jun, Zhang Zhongyang, Joseph John, Zhang Xingcai, Ferdows Bijan Emiliano, Patel Dylan Neal, Chen Wei, Banfi Giuseppe, Molinaro Roberto, Cosco Donato, Kong Na, Joshi Nitin, Farokhzad Omid C, Corbo Claudia, Tao Wei
Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
School of Engineering and Applied Sciences Harvard University Cambridge Massachusetts USA.
Exploration (Beijing). 2021 Oct 30;1(2):20210011. doi: 10.1002/EXP.20210011. eCollection 2021 Oct.
Bone defects pose a heavy burden on patients, orthopedic surgeons, and public health resources. Various pathological conditions cause bone defects including trauma, tumors, inflammation, osteoporosis, and so forth. Auto- and allograft transplantation have been developed as the most commonly used clinic treatment methods, among which autologous bone grafts are the golden standard. Yet the repair of bone defects, especially large-volume defects in the geriatric population or those complicated with systemic disease, is still a challenge for regenerative medicine from the clinical perspective. The fast development of biomaterials and nanomedicine favors the emergence and promotion of efficient bone regeneration therapies. In this review, we briefly summarize the progress of novel biomaterial and nanomedical approaches to bone regeneration and then discuss the current challenges that still hinder their clinical applications in treating bone defects.
骨缺损给患者、骨科医生和公共卫生资源带来了沉重负担。多种病理状况可导致骨缺损,包括创伤、肿瘤、炎症、骨质疏松症等等。自体和异体移植已发展成为最常用的临床治疗方法,其中自体骨移植是金标准。然而,从临床角度来看,骨缺损的修复,尤其是老年人群中的大面积缺损或合并全身性疾病的缺损,对再生医学而言仍是一项挑战。生物材料和纳米医学的快速发展有利于高效骨再生疗法的出现和推广。在本综述中,我们简要总结了新型生物材料和纳米医学方法在骨再生方面的进展,然后讨论了目前仍阻碍其在治疗骨缺损临床应用的挑战。